HALT Fentanyl Act
Date Passed: The HALT Fentanyl Act was signed into law on July 16, 2025
Background:
Opioids are a major health issue in the United States, with opioids playing a significant role in overdose deaths. One of these opioids is Fentanyl, A drug legally used to treat severe acute or chronic pain. Outside of hospitals, fentanyl is illegally produced and distributed on the black market. Due to its potency, even small amounts can be dangerous when misused. In response to the illegal distribution of fentanyl, the HALT Fentanyl Act was passed, permanently classifying fentanyl related substances as Schedule I drugs under the Controlled Substances Act.
Summary:
The HALT Fentanyl Act (Halt All Lethal Trafficking of Fentanyl Act) is a federal law that permanently places all Fentanyl Related Substances (FRS) into Schedule I of the Controlled Substances Act. Of the five Schedules, Schedule I substances are defined as having high abuse potential and no accepted medical use. The act distinguishes fentanyl related substances from pharmaceutical fentanyl, which remains classified as Schedule II drugs due to it having approved medical uses for severe pain management. The act defines fentanyl related substances based on their chemical structure, meaning any substance chemically similar will fall under the same classification.
Impact:
The act allows law enforcement officers to classify all Fentanyl Related Substances as schedule I and long term authority to seize such substances. Possessing fentanyl and having intent to distribute is a felony and could lead to 5-40 years in prison depending on the amount. By permanently placing fentanyl related substances in the Schedule I category, The law will help prevent drug manufacturers from slightly changing the chemical composition of fentanyl to create a new drug that is not regulated. This will help reduce the illegal trafficking and distribution of dangerous synthetic opioids, which may help reduce the overdose deaths associated with such drugs.
Works Cited
“The HALT Fentanyl Act.” House Committee on Energy and Commerce, energycommerce.house.gov/haltfentanyl.
